Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. CT ORDER Other Confidential Order
  2. 10-K/A Report 10-K/A
  3. 4 Option exercise COO and Secretary acquired 5,918 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Shareholder vote results
  11. 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Material agreement · New debt or obligation
  15. DEFA14A Proxy Proxy Materials
  16. DEF 14A Proxy Proxy Statement
  17. 4 Insider Changes in Ownership
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 10-K Report Annual Report

Page 36 of 40 · 789 filings